During the past decade, Universitätsklinikum Hamburg-Eppendorf; Frauenklinik conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Hamburg-Eppendorf; Frauenklinik" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Cancer Aid" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Hamburg-Eppendorf; Frauenklinik" are "Breast Cancer" (5 trials), "Breast Neoplasms" (2 trials), "Cancer of Endometrium Stage I" (1 trials), "Cancer of Endometrium Stage II" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Universitätsklinikum Hamburg-Eppendorf; Frauenklinik" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Hamburg-Eppendorf; Frauenklinik" are "Drug" (11 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pertuzumab" (5 trials), "Trastuzumab" (5 trials), "Docetaxel" (4 trials), "Paclitaxel" (4 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Hamburg-Eppendorf; Frauenklinik" are 9 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Universitätsklinikum Hamburg-Eppendorf; Frauenklinik". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Universitätsklinikum Hamburg-Eppendorf; Frauenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Hamburg-Eppendorf; Frauenklinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".